(lp0
S'Enanta Pharmaceuticals Inc versus Xencor Inc Head to Head Compare CML News - 16 hours ago Xencor Inc has a higher fundamental rating then Enanta Pharmaceuticals Inc which has an impact on the head-to-head comparison.'
p1
aS'Enanta Pharmaceuticals to Present at the HC Wainwright 1 Business Wire  - Mar 27, 2017 WATERTOWN, Mass.----Enanta Pharmaceuticals, Inc. , a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that&nbsp;...'
p2
aS'News Enanta Pharmaceuticals Inc.ENTA Wall Street Journal - Mar 22, 2013 News Enanta Pharmaceuticals Inc.ENTA. Significant News Only. 03/22/17; The Wall Street Journal. Rare Discovery: A Value in the Biotech World.'
p3
aS'Enanta Pharmaceuticals, Inc. Common Stock Quote &amp; Summary Data Nasdaq - Nov 8, 2012 We are a research and development-focused biotechnology company that uses our robust, chemistry-driven approach and drug discovery capabilities to create small molecule drugs primarily for the treatment of viral infections and liver diseases.'
p4
aS'Why Enanta Pharmaceuticals Inc. Shares Shot Higher Motley Fool - Dec 10, 2013 What: Shares of Enanta Pharmaceuticals , a small-molecule drug developer targeted at infectious disease, soared as much as 20% after clinical partner AbbVie  reported positive results from its second phase 3 trial of six&nbsp;...AbbVie oral hep C drugs cure 96 percent in late stage trial - Reuters'
p5
aS'Enanta Pharmaceuticals Inc.  Soars 5.12% on March 23 Equities.com - Mar 23, 2017 Enanta Pharmaceuticals Inc.  had a good day on the market for Thursday March 23 as shares jumped 5.12% to close at $30.62.A look at a High Market Cap Stock: Enanta Pharmaceuticals, Inc., ENTA - The Daily LeicesterHot Stocks Report: Enanta Pharmaceuticals, Inc. , Vuzix Corporation  - Post Analyst'
p6
aS"Enanta: Half Cash, All Upside Seeking Alpha - Feb 28, 2017 Investors have likely been disappointed in the past year and three years, but the company's early stage pipeline could breathe new life into shares.Enanta Pharmaceuticals Inc.  Moves Lower on Volume Spike for February 28 - Equities.com"
p7
aS'A Fundamental Perspective On Enanta Pharmaceuticals Seeking Alpha - Nov 20, 2015 The FDA warning is related to the only approved drugs related to Enanta, thus makes this a very risky investment. Competition from GILD, JNJ and MRK is ... From my continuous market screening, one of the stocks that ticked the right boxes was Enanta ...'
p8
aS"Enanta Pharmaceuticals Inc  Shares Sold by Envestnet Asset Management Inc. The Cerbat Gem - Mar 26, 2017 Enanta Pharmaceuticals logo Envestnet Asset Management Inc. cut its position in shares of Enanta Pharmaceuticals Inc  by 5.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission&nbsp;...Bullish Trend Inside Spotlight: Enanta Pharmaceuticals, Inc.'s  stock ... - WsNews 4investorsWorth Watching Stocks: Enanta Pharmaceuticals, Inc.  , Kadmon ... - NYSE Journal "
p9
aS'Stock Returns: FibroGen Inc  is Beating Enanta Pharmaceuticals ... CML News - Mar 14, 2017 This is a snapshot to compare the stock returns for Enanta Pharmaceuticals Inc  versus FibroGen Inc  .'
p10
a.